Alex Ovadia - Check Cap CEO Director

CHEK Stock  USD 0.81  0.01  1.25%   

CEO

Mr. Alex Ovadia serves as Chief Executive Officer at CheckCap Ltd since February 26, 2018. His work experience includes the following roles Director of the Company US Subsidiary, Vice President Research and Development, Chief Operating Officer and Israeli Site Manager, Vice President of Research and Development, global director and senior manager for CT research and development Philips Healthcare CT Systems, Management Member at Philips Medical System Technologies Ltd and projectsystems engineering manager at Elbit Systems Ltd since 2018.
Age 62
Tenure 6 years
Address Check-Cap Building, Isfiya, Israel, 3009000
Phone972 4 830 3401
Webhttps://www.check-cap.com
Ovadia holds a BS degree in Electronic Engineering from the TechnionIsrael Institute of Technology.

Check Cap Management Efficiency

The company has return on total asset (ROA) of (0.3169) % which means that it has lost $0.3169 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5406) %, meaning that it created substantial loss on money invested by shareholders. Check Cap's management efficiency ratios could be used to measure how well Check Cap manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.74. The value of Return On Capital Employed is expected to slide to -0.85. At this time, Check Cap's Total Current Liabilities is quite stable compared to the past year. Change To Liabilities is expected to rise to about 239 K this year, although the value of Liabilities And Stockholders Equity will most likely fall to about 20.9 M.
Check Cap currently holds 1.33 M in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. Check Cap has a current ratio of 12.78, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Check Cap's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 7 records

CEO Age

Derek MaetzoldCastle Biosciences
62
Keith SullivanNeuronetics
66
Evguenia MBASera Prognostics
50
Brian HullingerPsychemedics
56
Scott HuttonBiodesix
52
Robert LeasureInotiv Inc
64
Timothy DamadianFonar
60
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. The company was incorporated in 2004 and is based in Isfiya, Israel. Check-Cap operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 81 people. Check Cap (CHEK) is traded on NASDAQ Exchange in USA. It is located in Check-Cap Building, Isfiya, Israel, 3009000 and employs 9 people. Check Cap is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Check Cap Leadership Team

Elected by the shareholders, the Check Cap's board of directors comprises two types of representatives: Check Cap inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Check. The board's role is to monitor Check Cap's management team and ensure that shareholders' interests are well served. Check Cap's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Check Cap's outside directors are responsible for providing unbiased perspectives on the board's policies.
Saar Levi, Interim Officer
Mira Rosenzweig, Executive Officer
David Benaim, Interim Officer
Joshua Belkar, Vice President - Operations
Alex Ovadia, CEO Director
Yoav Kimchy, Founder, CTO and Director
Noa MBA, Director Resources
Dan Hilerowitz, Chief Officer
Iris EvenTov, Interim Officer

Check Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Check Cap a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Check Cap is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Check Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Check Cap Stock. Highlighted below are key reports to facilitate an investment decision about Check Cap Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Check Cap. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
For more information on how to buy Check Stock please use our How to buy in Check Stock guide.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Check Cap. If investors know Check will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Check Cap listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.00)
Return On Assets
(0.32)
Return On Equity
(0.54)
The market value of Check Cap is measured differently than its book value, which is the value of Check that is recorded on the company's balance sheet. Investors also form their own opinion of Check Cap's value that differs from its market value or its book value, called intrinsic value, which is Check Cap's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Check Cap's market value can be influenced by many factors that don't directly affect Check Cap's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Check Cap's value and its price as these two are different measures arrived at by different means. Investors typically determine if Check Cap is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Check Cap's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.